Articles tagged with Trikafta
Pharmac Expands Funding for Trikafta, Alyftrek & Kalydeco for All Children with Cystic Fibrosis
3 weeks ago | 238 viewsAssociate Health Minister David Seymour welcomes Pharmac’s decision to fund Trikafta and Alyftrek for all children with cystic fibrosis regardless of age from April 1, 2026, expanding access beyond the previous age limits. Pharmac will also widen access to Kalydeco for all eligible patients and allow doctors to prescribe these lifechanging treatments based on clinical judgment, addressing the urgent needs of young children affected by cystic fibrosis. This decision follows positive public consultation and reflects Pharmac’s commitment to working with the cystic fibrosis community to improve health outcomes and reduce pressure on the health system.
Tags: David Seymour Pharmac Trikafta Alyftrek Kalydeco cystic fibrosis children health minister New Zealand funding decisionPharmac Proposes Funding Trikafta and Alyftrek for All Children with Cystic Fibrosis
3 months ago | 459 viewsAssociate Health Minister David Seymour supports Pharmac’s public consultation on funding Trikafta and Alyftrek for children with cystic fibrosis of all ages, aiming to expand access beyond the current age restrictions. If approved, the proposal effective from April 1, 2026, would allow doctors to prescribe these life-changing treatments based on clinical need, addressing early harm caused by cystic fibrosis and improving patient outcomes. Pharmac encourages feedback from patients, families, healthcare professionals, and advocacy groups before the consultation closes on February 11, 2026.
Tags: David Seymour Pharmac Trikafta Alyftrek Kalydeco cystic fibrosis Associate Health Minister New Zealand public consultation healthcare